Spun out of Harvard and MIT in 2020, March Therapeutics is leveraging the founding team's broad domain expertise in DNA writing & genome engineering, synthetic gene circuit design & engineering, and bacterial & viral engineering to build a scalable platform for mitochondrial genome engineering.
Employees: 1-10
Founded date: 2020